Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

Cheap OEM Software
  

Search in our Online Store
Oncology
Filter     Order     Display # 
Date Item Title
13 Oct 2008 GTx Announces Investigational Ostarine(TM) (MK-2866) Met the Primary Endpoint in the Phase II Cancer Cachexia Clinical Trial
13 Oct 2008 OncoGenex Achieves Key Regulatory Milestone for Lead Product Candidate, OGX-011
13 Oct 2008 Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy
10 Oct 2008 Cyto Pulse, the Karolinska Institute and Uppsala University Hospital Receive Approval from the Swedish Medical Products Agency to Start a Clinical Trial Using a Xenogenic PSA DNA Vaccine
09 Oct 2008 EpiCept Receives Ceplene(R) Marketing Approval in Europe
08 Oct 2008 Nventa Presents Findings on Proprietary Toll-Like Receptor 3 (TLR3) Agonist, Poly.ICR, at World Vaccine Congress
08 Oct 2008 Genmab Reports Results of Portfolio Review
07 Oct 2008 Pivotal Phase III study shows MabThera delays disease progression in patients with relapsed or refractory Chronic Lymphocytic Leukaemia
07 Oct 2008 Biovest Announces BiovaxID(R) Anti-Cancer Vaccine Prolongs Cancer-Free Survival by 44%
07 Oct 2008 Bavarian Nordic announces positive mature Phase II results from newly acquired prostate cancer vaccine
07 Oct 2008 Oral anticancer drug CP-4126 enters Clinical Phase I study
07 Oct 2008 Antisoma and The Institute of Cancer Research to collaborate on novel approach to cancer treatment
07 Oct 2008 Oxford Biomedica Announces FDA Agreement on Revisions for Ongoing Trovax Phase III Trist Study
07 Oct 2008 Apogenix Starts Phase I With its Lead Compound AGP101
06 Oct 2008 Roche announces topline outcomes for Avastin-Tarceva combination study in advanced lung cancer
06 Oct 2008 Oncalis AG Licenses PI3K Inhibitors From ChemDiv Inc.
06 Oct 2008 Novo Nordisk and Innate Pharma swap product rights
05 Oct 2008 Lilly and Deciphera Pharmaceuticals Announce Licensing and Collaboration Agreement
05 Oct 2008 Exelixis Files IND Application for XL888
05 Oct 2008 Genentech, Glycart and Roche enter into collaboration agreement for potential cancer therapy
02 Oct 2008 Cell Therapeutics Submits Supplemental Biologics License Application for Zevalin Use in First-Line Consolidation Therapy
02 Oct 2008 Access Pharmaceuticals Presents New Data on the Company's Angiolix(R) Therapeutic Monoclonal Antibody
02 Oct 2008 ArQule Achieves Clinical Milestone in MiT Trial with ARQ 197
02 Oct 2008 Æterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108
01 Oct 2008 Apthera Announces Optimal Dose and Schedule of NeuVax for Phase III Clinical Trial in Breast Cancer
01 Oct 2008 Idera Pharmaceuticals Announces Preliminary Data from Phase 2a Clinical Study of IMO-2055 Monotherapy in Renal Cell Carcinoma
30 Sep 2008 Antisoma starts phase II trial of AS1402 in breast cancer
30 Sep 2008 Phase 2 Study of IMC-1121B for Advanced Ovarian Cancer Commences Patient Enrollment
30 Sep 2008 A.P. Pharma Announces Positive Phase 3 Results with APF530 in the Prevention of CINV
29 Sep 2008 Dosing Initiated in TransMolecular’s Phase 1/2 Clinical Trial for Intravenous Administration of 131Iodine-TM601 in Patients with Recurrent Malignant Glioma
29 Sep 2008 CombiMatrix Announces That Permission Has Been Granted to Begin Clinical Trial for Leuchemix Drug
29 Sep 2008 FDA Grants Lilly's ALIMTA(R) (Pemetrexed for Injection) Third U.S. Approval
28 Sep 2008 Thallion Enrolls First Patient in TLN-4601 Phase II Trial
25 Sep 2008 Randomized Phase 2 Study of IMC-A12 for Advanced Breast Cancer Commences Patient Enrollment
25 Sep 2008 Ipsen announces the filing of Decapeptyl(R) 6-month formulation for the treatment of locally advanced or metastatic prostate cancer in Europe
24 Sep 2008 Ortho Biotech Oncology Research & Development Unites Johnson & Johnson Biopharmaceutical Oncology R&D Assets
24 Sep 2008 Cornerstone Pharmaceuticals Announces Initiation of Clinical Trials of CPI-613 for the Treatment of Cancer
24 Sep 2008 QuatRx Pharmaceuticals Announces Additional Data From Phase 3 Study for Ophena(TM) (Ospemifene Tablets) Showing Improvements in Clinical Symptoms of Vulvovaginal Atrophy
23 Sep 2008 AVEO Initiates First Clinical Trial of Novel HGF Antagonist
23 Sep 2008 ERBITUX(R) Five-Year Data Show Significant Improvement in Overall Survival for Patients with Locally or Regionally Advanced Head and Neck Cancer
22 Sep 2008 Recruitment Completed In Ofatumumab NHL Front Line Study
21 Sep 2008 Transgene's Therapeutic Vaccine TG4010: Promising Additional Clinical Data in Non Small Cell Lung Cancer Phase IIb Trial
18 Sep 2008 Multi-Pronged Therapeutic Cancer Vaccine Regimen to be Studied in Melanoma Patients
17 Sep 2008 InNexus Lead Candidate DXL625 Outperforms Rituxan in Additional Animal Studies
17 Sep 2008 Threshold Pharmaceuticals Initiates a Clinical Trial Evaluating TH-302 in Patients With Soft Tissue Sarcoma
16 Sep 2008 MediGene reports positive 12-month survival data for EndoTAGTM-1 from Phase II pancreatic cancer study
16 Sep 2008 Pharmamar Pivotal Study if Yondelis(R) in Ovaria Cancer Shows a Statistically Significant and Clinically Meaningful Prolongation in Progression Free Survival
16 Sep 2008 Pazopanib shows encouraging activity in several tumour types, including soft tissue sarcoma and ovarian cancer
16 Sep 2008 Merck KGaA: New First-Line Data Demonstrate Response Rates of Up to 80% for Erbitux in KRAS Wild-Type Metastatic Colorectal Cancer (mCRC)
16 Sep 2008 New data confirms Avastin as the only biologic to demonstrate overall survival when used first-line in metastatic colorectal cancer patients with K-RAS (wild-type) gene status
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Results 101 - 150 of 2757

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Diabetes Drug Pipeline

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics